Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with papillary thyroid cancer (a specific type of thyroid cancer), confirmed by a needle biopsy test
- Genetic testing done before surgery showed that your cancer has a "low-risk" gene mutation type
- You do not have any serious conditions such as heart failure, severe breathing problems, or kidney failure
- Your medical records and follow-up information are complete and available
Who may not be able to join:
- Your scans (such as ultrasound or CT) showed that the cancer has spread to nearby areas or other parts of the body
- You did not have genetic testing before surgery, or the results of your genetic test could not be properly evaluated
- You are unable to attend regular follow-up appointments, or you stopped attending follow-up visits during the study
Note on "low-risk" thyroid cancer — as defined by this trial, this generally means:
- The tumour is 1 cm or smaller
- There is only one tumour (not multiple)
- The cancer has not spread to other areas
- The cancer has not grown into surrounding tissues or blood vessels
- The tumour is not one of the more aggressive subtypes (confirm with trial site)
- You have no history of radiation treatment to the head or neck in childhood or teenage years
- You have no family history of thyroid cancer
- Your genetic test shows specific low-risk mutations (confirm exact mutation type with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Miaoyun Long, MD, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phone: 86-34070602
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.